tradingkey.logo
搜索

X4 Pharmaceuticals Inc

XFOR
添加自选
3.980USD
-0.020-0.50%
收盘 07-31 16:00美东报价延迟15分钟
375.39M总市值
亏损市盈率 TTM

XFOR 财务数据

通过专为投资者打造的一站式数据看板,全面查看 X4 Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

X4 Pharmaceuticals Inc财报日历

最新发布
5月 6, 2026
每股收益 / 预测值
-0.21/-0.20
营业收入 / 预测值
2.71M/3.20M
报告期
FY2025 财报
营业收入(YoY)
35.11M
1273.21%
每股收益(YoY)
-1.87
66.49%
分析师评级
STRONG BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-113.36%-0.16
95.53%-0.26
78.37%-1.19
-125.54%-3.47
115.45%1.20
-104.11%-5.89
-1461.45%-5.48
237.25%13.60
-57.29%-7.77
66.58%-2.88
---0.35
---9.91
---4.94
---8.63
---39.61
----
----
----
----
----
营业收入
-90.60%2.71M
79.08%2.57M
215.18%1.76M
250.44%1.97M
--28.81M
--1.43M
--560.00K
--563.00K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
净利润
-7277.66%-20.24M
39.92%-23.93M
18.75%-29.82M
-128.34%-25.74M
100.54%282.00K
-108.16%-39.82M
-1492.02%-36.70M
263.04%90.83M
-115.51%-51.77M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
18.96%-29.10M
-8.42%-21.87M
-8.02%-21.21M
10.00%-24.22M
-95.17%-35.91M
-15.62%-20.18M
-29.68%-19.64M
利润率
-76453.98%-747.45%
66.45%-931.66%
74.22%-1689.24%
-108.09%-1304.66%
--0.98%
---2776.92%
---6552.86%
--16133.75%
----
----
----
----
----
----
----
----
----
----
----
----
毛利率
-6.83%77.92%
8.72%85.83%
34.73%80.11%
59.31%83.48%
--83.63%
--78.94%
--59.46%
--52.40%
----
----
----
----
----
----
----
----
----
----
----
----
资产负债率
-51.33%28.31%
-49.00%26.27%
10.15%46.51%
102.43%72.11%
19.03%58.17%
38.98%51.50%
34.69%42.22%
89.49%35.62%
87.76%48.87%
71.50%37.06%
--31.35%
--18.80%
--26.03%
--21.61%
--29.41%
----
----
----
----
----
营业收入
-90.60%2.71M
79.08%2.57M
215.18%1.76M
250.44%1.97M
--28.81M
--1.43M
--560.00K
--563.00K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
营业利润
-115.04%-20.31M
33.64%-23.70M
20.26%-27.51M
22.61%-26.23M
74.68%-9.44M
-41.73%-35.72M
-26.77%-34.50M
-31.36%-33.90M
-27.25%-37.29M
1.48%-25.20M
-35.03%-27.21M
-25.45%-25.80M
-34.56%-29.30M
-32.54%-25.58M
-5.41%-20.15M
-8.28%-20.57M
-21.42%-21.78M
-9.30%-19.30M
-12.60%-19.12M
-29.60%-19.00M
净利润
-7277.66%-20.24M
39.92%-23.93M
18.75%-29.82M
-128.34%-25.74M
100.54%282.00K
-108.16%-39.82M
-1492.02%-36.70M
263.04%90.83M
-115.51%-51.77M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
18.96%-29.10M
-8.42%-21.87M
-8.02%-21.21M
10.00%-24.22M
-95.17%-35.91M
-15.62%-20.18M
-29.68%-19.64M
流动资产
152.86%241.98M
133.19%261.58M
-7.11%132.81M
-58.42%72.94M
9.58%95.70M
-8.11%112.17M
-3.31%142.97M
18.81%175.42M
-11.09%87.33M
-5.13%122.08M
72.51%147.87M
180.78%147.65M
38.57%98.22M
46.43%128.68M
6.22%85.72M
-48.13%52.59M
-40.91%70.88M
5.49%87.88M
-14.07%80.70M
-7.75%101.37M
流动负债总额
-8.16%23.77M
-21.66%25.76M
-19.66%23.51M
-20.78%22.90M
9.95%25.88M
43.81%32.88M
15.04%29.26M
29.89%28.90M
20.83%23.54M
2.41%22.86M
-11.43%25.43M
1.13%22.25M
30.15%19.48M
59.20%22.32M
117.00%28.71M
67.70%22.00M
2.03%14.97M
17.37%14.02M
0.40%13.23M
21.70%13.12M
总资产
107.89%270.28M
98.34%290.46M
-8.20%163.56M
-50.07%105.17M
15.89%130.01M
-0.55%146.45M
2.81%178.16M
21.46%210.61M
-9.83%112.18M
-5.35%147.26M
52.81%173.29M
114.02%173.40M
24.87%124.41M
32.78%155.59M
-5.90%113.41M
-42.81%81.02M
-38.13%99.63M
-4.63%117.18M
-9.47%120.52M
-0.61%141.66M
总负债
-4.89%101.83M
-16.19%104.17M
-14.01%101.94M
-12.88%101.20M
-3.67%107.07M
29.26%124.30M
12.15%118.54M
9.73%116.16M
52.82%111.15M
17.94%96.16M
105.01%105.70M
107.80%105.86M
45.72%72.73M
54.53%81.53M
-0.54%51.56M
-2.86%50.95M
-7.74%49.91M
5.38%52.76M
19.39%51.84M
39.30%52.45M
总权益
634.18%168.45M
741.08%186.29M
3.35%61.62M
-95.80%3.97M
2114.67%22.94M
-56.65%22.15M
-11.80%59.62M
39.85%94.45M
-98.00%1.04M
-30.99%51.10M
9.29%67.59M
124.57%67.53M
3.95%51.68M
14.96%74.05M
-9.94%61.85M
-66.29%30.07M
-53.51%49.71M
-11.52%64.41M
-23.44%68.68M
-14.94%89.21M
经营净额
-58.47%-19.60M
52.94%-15.53M
18.25%-27.82M
1.24%-29.90M
63.19%-12.37M
-18.91%-32.99M
-63.40%-34.03M
-41.32%-30.28M
-26.72%-33.60M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-0.21%-19.09M
-35.85%-19.31M
3.77%-18.47M
-9.68%-20.23M
-8.85%-19.05M
0.82%-14.21M
-67.53%-19.20M
投资净额
713.51%19.25M
295.44%16.85M
-79.98%-28.67M
-76.14%23.11M
41.04%-3.14M
-78.38%-8.62M
-208.88%-15.93M
2083.25%96.86M
-59033.33%-5.32M
-14114.71%-4.83M
-57200.00%-5.16M
-12752.63%-4.88M
59.09%-9.00K
-161.54%-34.00K
55.00%-9.00K
55.81%-38.00K
95.56%-22.00K
95.70%-13.00K
95.97%-20.00K
-855.56%-86.00K
融资净额
--2.00K
108116.30%146.09M
--86.91M
-72.07%5.63M
--0.00
39.18%135.00K
-100.00%0.00
-70.93%20.16M
100.00%0.00
-99.84%97.00K
-59.20%21.20M
20082.13%69.34M
-142.86%-2.12M
146.82%60.64M
1270.13%51.98M
62.45%-347.00K
-91.00%4.96M
222.06%24.57M
-1464.08%-4.44M
-1521.54%-924.00K

常见问题

X4 Pharmaceuticals Inc的总收入是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,总收入达到了35.11M(同比变化2.56M)。

X4 Pharmaceuticals Inc的流动资产是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,流动资产为261.58M(同比变化133.19)。

X4 Pharmaceuticals Inc的总资产是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的总资产为290.46M(同比变化98.34)。

X4 Pharmaceuticals Inc的总负债是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的总负债为104.17M(同比变化-16.19)。

X4 Pharmaceuticals Inc的总权益是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的总权益为186.29M(同比变化741.08)。

X4 Pharmaceuticals Inc的净营业收入是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的净营业收入为-86.88M(同比变化38.56)。

X4 Pharmaceuticals Inc的净投资是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的净投资为8.15M(同比变化-87.83)。

X4 Pharmaceuticals Inc的净融资是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,X4 Pharmaceuticals Inc的净融资为238.63M(同比变化1075.85)。

X4 Pharmaceuticals Inc的每股收益(EPS)是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.87(同比变化66.49)。

X4 Pharmaceuticals Inc的净利润是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,净利润为-79.20M(同比变化-111.48)。

X4 Pharmaceuticals Inc的净利润率是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,净利润率为-225.55(同比变化84.60)。

X4 Pharmaceuticals Inc的毛利率是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,毛利率为83.60(同比变化21.46)。

X4 Pharmaceuticals Inc的债务与资产比率是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,债务与资产比率为26.27(同比变化-49.00)。

X4 Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-75.99(同比变化25.68)。

X4 Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-36.25(同比变化-42.16)。

X4 Pharmaceuticals Inc的营业利润是多少?

根据X4 Pharmaceuticals Inc的FY2025财报,营业利润为-86.88M(同比变化38.56)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有